An indicator for evaluating the risk of cancerous transformations of human induced pluripotent stem cells

Hepatology

Volumn 51, Issue 3, 2010, Pages 1085-1086

  Moriguchi, Hisashi ^a,b,c   Chung, Raymond T ^b   Sato, Chifumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOCEPREVIR; CD31 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERFERON; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; P21 ACTIVATED KINASE; RIBAVIRIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SOX2; TUMOR MARKER;

ANGIOGENESIS; ANIMAL EXPERIMENT; CANCER RISK; CARCINOGENESIS; CELL DENSITY; CELL DIFFERENTIATION; CELL TRANSFORMATION; CELL TRANSPLANTATION; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG TOXICITY; EPIGENETICS; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; INOCULATION; LETTER; LIVER CELL; MICROVASCULATURE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SCID MOUSE; STEM CELL; TERATOMA;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; RISK ASSESSMENT;

EID: 77950603864     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23379     Document Type: Letter

References (5)

1. Susser S, Welsch C, Wang Y, Zettler M, Domingues FS, Karey U, et al. Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients. HEPATOLOGY 2009; doi:10.1002/hep.23192.
2. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. HEPATOLOGY 2009; doi:10.1002/hep.23354.
3. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnol 2008;26:101-106.
4. Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 2009;459:1126-1130.
5. Shirako E, Hirayama N, Tsukada Y, Tanaka T, Kitamura N. Up-regulation of p21CIP1 expression mediated by ERK-dependent and-independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation. J Cell Biochem 2008;104:176-188.